LICENSE AGREEMENTLicense Agreement • August 14th, 2001 • Martha Stewart Living Omnimedia Inc • Periodicals: publishing or publishing & printing • Michigan
RECITALSSecurity Agreement • June 30th, 1997 • Sled Dogs Co • Sporting & athletic goods, nec • Minnesota
EXHIBIT #3 SECOND AMENDMENT TO SETTLEMENT AGREEMENT This SECOND AMENDMENT TO SETTLEMENT AGREEMENT (the "Second Amendment") is made effective as of the 17TH day of July, 1997 by and among Frank Manchak, Jr., an individual ("Manchak"); N-Viro Energy...Settlement Agreement • July 18th, 1997 • N-Viro International Corp • Patent owners & lessors • California
FORM OF UNDERWRITING AGREEMENT ------------------------------Bionx Implants Inc • April 23rd, 1997 • Surgical & medical instruments & apparatus • New York
THE SECURITY REPRESENTED BY THIS CERTIFICATE HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISPOSITION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT...Nonstatutory Stock Option Agreement • November 15th, 1999 • Senesco Technologies Inc • Blank checks
EXHIBIT 3.12 CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS DOCUMENT. CONFIDENTIAL PROVISIONS HAVE BEEN OBSCURED. BIOVATION LIMITED EXCLUSIVE LICENSE AGREEMENT This Exclusive License Agreement (this "Agreement") is made as of the 8th...Exclusive License Agreement • June 17th, 2005 • Viventia Biotech Inc. • New York
Warrant No.[ ] Number of Shares:[ ] (subject to adjustment) Date of Issuance: [ ]Senesco Technologies Inc • February 14th, 2002 • Services-commercial physical & biological research • New Jersey
CREDIT AGREEMENT among Response genetics, inc., as Borrower, SWK FUNDING LLC, as Agent, Sole Lead Arranger and Sole Bookrunner, and the financial institutions party hereto from time to time as Lenders Dated as of July 30, 2014Credit Agreement • February 2nd, 2015 • SWK Holdings Corp • Miscellaneous business credit institution • New York
This Note has been issued pursuant to the Credit Agreement, and all of the terms, covenants and conditions of the Credit Agreement (including all Exhibits and Schedules thereto) and all other instruments evidencing or securing the indebtedness hereunder are hereby made a part of this Note and are deemed incorporated herein in full.
ASSET PURCHASE AGREEMENT by and among K-V PHARMACEUTICAL COMPANY and VIVUS, INC. dated as of March 30, 2007Asset Purchase Agreement • May 21st, 2007 • Vivus Inc • Pharmaceutical preparations • Delaware
This Asset Purchase Agreement (this “Agreement”) is made and entered into as of March 30, 2007, by and among K-V Pharmaceutical Company, a Delaware corporation (the “Acquiror”), and Vivus, Inc., a Delaware corporation (the “Seller”).
LICENSE AGREEMENTLicense Agreement • May 3rd, 2010 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Illinois
This AGREEMENT (“Agreement”), dated December 3, 2008 is made by and between BioSante Pharmaceuticals, Inc., 111 Barclay Boulevard, Lincolnshire, IL 60069 (“BPA”), and Azur Pharma International II Limited, a Bermuda limited liability company, Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda and such of its Affiliates as it may designate from time to time under one or more provisions of this Agreement (“Company”).
This ASSIGNMENT AND MUTUAL RELEASE AGREEMENT (thisAssignment and Mutual Release Agreement • June 22nd, 2006 • New York
WHEREAS, Assignor and Assignee are parties to a certain License Agreement dated as of September 1, 2000 (the “License Agreement”), pursuant to which Assignor granted to Assignee an exclusive world-wide license to make, have made, use, lease, sell, offer for sale, export and import Licensed Products and to practice Licensed Processes based on certain Patent Rights, and granted Assignee certain rights with respect to Related Technology, as such capitalized terms are defined the License Agreement; and
RECITALSAssignment and Asset Transfer Agreement • November 13th, 2001 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
1 Exhibit 10.154 [Letterhead of Kenyon & Kenyon, Washington D.C.] February 25, 1997 VIA FACSIMILE - (419) 241-6894 ------------------------------ Peter R. Silverman, Esq. SHUMAKER, LOOP & KENDRICK, LLP 1000 Jackson Toledo, Ohio 43624-1573 Re: Manchak...N-Viro International Corp • April 15th, 1997 • Patent owners & lessors
1 EXHIBIT 10.9 [Letterhead of Transcend Therapeutics, Inc.] October 4, 1995 Mr. H. Walter Hauessler President, Director Patents & Technology Marketing Cornell Research Foundation, Inc. Cornell Business & Technology Park 20 Thornwood Drive, Suite 105...Transcend Therapeutics Inc • March 5th, 1997 • Biological products, (no disgnostic substances)
MACHINERY AND EQUIPMENT LOAN FUND LOAN AGREEMENTLoan Agreement • May 14th, 2007 • Power Medical Interventions, Inc.
THIS LOAN AGREEMENT, MADE this 21 day of December, 2005, effective as of December 21, 2005 (the “Effective Date”) BY AND BETWEEN POWER MEDICAL INTERVENTIONS, INC., a corporation organized and existing under the laws of Delaware and having an address of 2021 Cabot Boulevard West, Langhorne, Pennsylvania 19047 (the “Borrower”) and THE COMMONWEALTH OF PENNSYLVANIA, acting by and through the DEPARTMENT OF COMMUNITY AND ECONOMIC DEVELOPMENT, having its principal place of business at Commonwealth Keystone Building, 400 North Street, Fourth Floor, Harrisburg, Pennsylvania 17120 (the “Department”).
